chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diagnosed with myofascial; This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown, at the age of 68-year-old), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported, she was diagnosed with myofascial and she wants to try this new medication because it has something to do with the nerves and muscles and just started taking it last week. Patient also stated, she had to be off of the Xeljanz for two weeks because of the COVID vaccine and started back on its last night and she could feel the difference. Outcome of event was unknown.  Information about Lot/batch number has been requested.
Pharmacist injected into the incorrect part of the upper left arm. Patient identifies posterior aspect of left upper arm as site of injection.  Patient claims that the moment the needle went into the posterior upper area of the arm, the nerve was hit and immediately felt pain above typical IM injection pain.  It had progressed in intensity causing her to seek medical attention numerous times.  The pain (continuous burning and stabbing) intensity has come down in two months, but is still persistent.  The patient came in to the pharmacy on 1.4.2020 to report it to me because she wanted to confront the pharmacist who gave her the vaccine.  The pharmacist was a floater and does not work steadily at this location.  She did not want to get the pharmacist in trouble was her rationale for not reporting it sooner.
Initially light headed feeling then throat soreness and then chest tightness.  Benadryl 50 mg IM given with no relief.  EMS called and transported to hospital.
Little itching; Rash around injection site around an inch; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Mar-2021 and was forwarded to Moderna on 06-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Little itching) and INJECTION SITE RASH (Rash around injection site around an inch) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L204) for COVID-19 vaccination.     Concomitant products included HYDROCHLOROTHIAZIDE and SIMVASTATIN for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced INJECTION SITE PRURITUS (Little itching) and INJECTION SITE RASH (Rash around injection site around an inch). At the time of the report, INJECTION SITE PRURITUS (Little itching) and INJECTION SITE RASH (Rash around injection site around an inch) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Patient immediately complained of blurry vision and lightheadedness after injection. Patient proceeded to having a syncopal episode after about 3 minutes. Patient returned to consciousness almost immediately. The paramedics arrived within 5 minutes and checked patient vitals. Patient was fine and left pharmacy in good condition.
I got the vaccine on Thursday afternoon, and had a grand mal seizure on Sunday. I was taken to the ER where I was given Ativan, and had blood and urine samples taken and a CT scan. All test results came back normal. I have a follow up appointment with a neurologist today (Tuesday 4/13).
Back in October of 2021 I went to the Emergency room feeling very sick and was diagnosed with Acute Lymphoblastic Leukemia.   I have been in the hospital many times, admitted for weeks at a time, and am currently receiving chemo, platlets and many tests.
pt recvd MMR vax & 24 hrs following vax pt devel nausea, aches, pain & flu-like sx; no further details were provided;
severe double vision issues; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: DIPLOPIA (non-serious), outcome "unknown", described as "severe double vision issues".  Additional information: Reporter reported that, he/she felt that the ad was misleading as he/she have witnessed that his/her family member developed severe double vision issues after the vaccine.  Follow-up attempts are completed. No further information is expected.
Left arm (deltoid) pain, swelling, knot in the muscle larger than my entire hand, redness, hot to the touch. Migraine, severe fatigue, muscle and joint pain to the point of barely being able to move from the bed, not able to take a deep breath without pain, brain fog, loss of concentration, difficulty with word recall
This spontaneous report as received from a nurse refers to a 16 year old patient of an unknown gender. On 02-MAR-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Local pain and swelling of the injection site occurred within 24 hours.  Bruising /discoloration at injection site began within 7 days.  Within 2 weeks, the injection soreness returned along with muscle weakness followed by atrophy.  It has been 5 months and now there is a persistent and visible concavity/indentation of the injection site.  An irreversible erosion of the flesh.  Not a disability but permanent damage
4x4 red, hot, extremely itchy patch at the injection site; Itching; It looked red; Chills; Fever; Nausea; Extra fatigued; Diarrhea; Total weakness; Achiness; Soreness; Redness; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Total weakness), PAIN (Achiness), VACCINATION SITE ERYTHEMA (Redness), CHILLS (Chills) and NAUSEA (Nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia, Arthritis, Arrhythmia, Hypertension and Anxiety. Concomitant products included CELECOXIB (CELEXA [CELECOXIB]) and ALPRAZOLAM (XANAX) for Anxiety, TRAMADOL for Arthritis, PARACETAMOL (TYLENOL) for Fibromyalgia, LISINOPRIL for Hypertension.  On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness). On 05-Feb-2021, the patient experienced ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea). On 13-Feb-2021, the patient experienced PRURITUS (Itching) and ERYTHEMA (It looked red). On 06-Feb-2021, ASTHENIA (Total weakness), PAIN (Achiness), CHILLS (Chills) and NAUSEA (Nausea) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Redness) outcome was unknown and PRURITUS (Itching) and ERYTHEMA (It looked red) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information include Benadryl, Cortisone cream.
This case was reported by a consumer via call center representative and described the occurrence of localized erythema in a adult female patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced localized erythema. On an unknown date, the outcome of the localized erythema was recovered/resolved. The reporter considered the localized erythema to be possibly related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The caller was placed on phone by retired GSK employee. She states another female worker at the store received SHINGRIX and had a red streak from the top of her shoulder down to the injection site. No other details were known. Encouraged to have individual contact GSK to report events as well, and it was a follow up call. The caller was cashier at pharmacy. This case has been linked with US2018071883 and US2018071881, reported by the same reporter.
Pain at injection site. Slight chills. Night sweats with sleep terrors. Slight lymphadenopathy. Slight dizziness.
From initial information received on Apr 15 2005 from a health care professional regarding an adverse event it was reported that a three month old male patient received a dose of ACTHIB, lot number X0879 (UE387AA), administered intra muscularly in the left thigh, a dose of IPOL, lot number X0707, administered subcutaneously in the right thigh, and a dose of Tripedia, lot number U1290BA, administered intramuscularly in the right thigh on Feb 8 2005 in the morning. He also received a dose of Prevnar lot number A65653K administered intramuscularly in the left thigh in the same day. An unspecified amount of hours later, in the afternoon of Feb 8 2005, the patient had a temperature of 103 degrees F. He was not seen by the physician, but was treated with Tylenol and recovered from these events.
T 39, diarrhea, mottled, decreased cap refill required. Suspect mild virus infection. Note: stool sent to office for dsRNA rotavirus genome testing.  2/17/09 Received hospital medical records of 1/26-1/31/2009. FINAL DX: Rotavirus, dehydration resolved Records reveal patient experienced yellow watery diarrhea, fever, irritability, oral intake reduced x 2 days & decreased UOP x 1 days.  Exam revealed mottled skin, delayed cap refill, fever of 39.3 & dry lips.  Tx w/IVF & formula change.  Improved & d/c to home.  Sibling also developed watery diarrhea.
side effects after my second shot if i got it them the first time(first dose); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects after my second shot if i got it them the first time(first dose)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects after my second shot if i got it them the first time(first dose)). At the time of the report, VACCINATION COMPLICATION (side effects after my second shot if i got it them the first time(first dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Consent for follow up declined.  No concomitant medication was provided by reporter. No treatment information was provided by reporter.   Reporter did not allow further contact
Itching and red rash surrounding area in two places. Has had symptoms for three days, Headache noted.
rash on right arm near the spot where the vaccine was given; Tired; right arm around where the vaccine was given began to ache; Chills; after 30 hours later he had problem of aches; Pain in elbow/Aching in elbow, wrist pain; Dry feeling in mouth; Pain in middle finger of left arm, Pain in wrist; metallic like taste; warm feeling in arms and hands; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry feeling in mouth), PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), DYSGEUSIA (metallic like taste), FEELING HOT (warm feeling in arms and hands) and VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder and Food allergy. Concomitant products included SIMVASTATIN for Cholesterol, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for Hypothyroidism, SIMVASTATIN (ZOCOR), MORNIFLUMATE (FLOMAX [MORNIFLUMATE]) and TAMSULOSIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced DRY MOUTH (Dry feeling in mouth), PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), DYSGEUSIA (metallic like taste), FEELING HOT (warm feeling in arms and hands), MYALGIA (after 30 hours later he had problem of aches) and ARTHRALGIA (Pain in elbow/Aching in elbow, wrist pain). On 18-Mar-2021, the patient experienced FATIGUE (Tired), VACCINATION SITE PAIN (right arm around where the vaccine was given began to ache) and CHILLS (Chills). On an unknown date, the patient experienced VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given). On 18-Mar-2021, DRY MOUTH (Dry feeling in mouth), DYSGEUSIA (metallic like taste) and FEELING HOT (warm feeling in arms and hands) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain in middle finger of left arm, Pain in wrist), MYALGIA (after 30 hours later he had problem of aches) and ARTHRALGIA (Pain in elbow/Aching in elbow, wrist pain) had resolved and VACCINATION SITE RASH (rash on right arm near the spot where the vaccine was given), FATIGUE (Tired), VACCINATION SITE PAIN (right arm around where the vaccine was given began to ache) and CHILLS (Chills) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medication information was reported.       Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Allergy, Concomitant and new Events are updated.
15 minutes after vaccine- hot all over body, throat closing, itchy, eyes felt weird,  dizzy, and rapid heart rate
Cellulitis with swelling and hot inflammation and infection. It progressed and spreaded down ford to arm area, pt was hospitalized with antibiotic drip
pt given dose out of vial in fridge that had been punctured about 24 hours before vaccine given.  Should have been used within 12 hours.  no adverse reaction per patient with follow up call 6/22/21 - per Moderna called and no information on vaccine after 12 hours and no recommendation on how to proceed other than call to see if patient having any side effects
On Monday pt received Quadracel and Flu in L leg, Proquad in R. Mom called today stating she believes it patient's L leg. It is swollen and the  diameter of an orange, is very warm, hard and a little firm at the site. Tuesday morning it was size of a nickle, by bedtime the diameter was the size of a golf ball and woke up with a diameter the size of an orange today, 9/21/22. Only other red marks are on a foot and on the back. Mom thinks those are mosquito bites. Pt is not having any difficulty breathing. No swallowing issues. Originally scheduled for an in office at 2  pm with , FNP . Because of transportation issues, switched to telemedicine. Mom has been using cold compresses on site and will continue to do so. Per the visit: localized superficial swelling of skin (Left) Child developed localized reaction s/p Dtap, IPV, and flu vaccine in L thigh 24 hours after vaccines given as evidenced by mild to moderate erythema currently 4 inches in diameter without tenderness or decreased ROM of extremity. Child did not have respiratory distress, swelling of face, wheezing or hives, so localized and minor. Discussed with mother over video visit that reaction is likely related to Dtap vaccine but flu vaccine is also possible culprit and is not indicative of allergy to vaccine components. Since erythema and warmth at the injection site is improving, advised to continue to use cool compresses at the area and monitor for danger signs as discussed. Mom to call hospital if noted.
Patient reports muscle aches and significant fatigue for 3 weeks following the second vaccination. Initially just with sore arm, then a few day later developed the fatigue
chills with shaking; low-grade fever; headache; lethargy; body aches; This is a spontaneous report from a contactable consumer (patient).  A 66-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via an unspecified route, administered in the left arm on 04Mar2021 01:15 PM (at the age of 66-years-old) as first dose, single dose for COVID-19 immunisation at a hospital. Medical history included Mediterranean anemia, bilateral profound hearing loss, gout and mild hypothyroidism; all from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine sodium, rosuvastatin calcium and febuxostat; all taken for an unspecified indication, start and stop dates were not reported. No other vaccine was given to the patient in four weeks. The patient had no COVID prior vaccination and was not tested for COVID post vaccination. The patient has no known allergies. On 05Mar2021 06:00 PM, the patient experienced chills with shaking, low-grade fever, headache, lethargy and body aches. No treatment was taken as a result of the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A week after the first dose of Moderna, symptom like chilblains appears on toes and heels on both feet. Itchy and pain. It get better after two days.
4 hours post vax, pts right deltoid swollen and erythematous. Treated with warm compresses.
Information has been received from a physician concerning a parent of a pediatric patient (WAES# 0605USA01775) who was vaccinated with a dose of Varivax. Subsequently the parent developed herpes zoster while their child was experiencing breakthrough varicella. There was no product quality complaint involved. Additional information has been requested.
Tenderness in arm soon after shot and quite tender for rest of the evening. Following day about 24 hours after shot, chills began.  Aches specifically felt in wrists and elbows.  Tingling sensations felt on backs of legs as if they were raw or had wind burn.  Took an Aleve which I feel kept any mild temperature at bay and helped with overall aches.  Also had a few bouts of nausea/lightheaded.  By about 30 hours, symptoms resided.  Tenderness at injection on arm continues to be tender.  No swelling however.
feeling ill; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Flu vaccine with an associated reaction of malaise (received on 10th October 2019 and experienced low energy, swollen lump,redness and soreness on achilles heel tendon,for tolerance of flu vaccine refer case US2019195528).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 72 or 73 years. The patient experienced feeling ill for one day after receiving Shingrix. The reporter consented to follow up.
Approximately one week of headaches, malaise, loose stools once to twice daily. All symptoms resolved within one week.
felt like something foreign put in my body; hard to describe, felt like a steroid shot; severe flu like symptoms; sweats; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of SENSATION OF FOREIGN BODY (felt like something foreign put in my body), FEELING ABNORMAL (hard to describe, felt like a steroid shot), INFLUENZA LIKE ILLNESS (severe flu like symptoms), HYPERHIDROSIS (sweats) and CHILLS (chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SENSATION OF FOREIGN BODY (felt like something foreign put in my body), FEELING ABNORMAL (hard to describe, felt like a steroid shot), INFLUENZA LIKE ILLNESS (severe flu like symptoms), HYPERHIDROSIS (sweats), CHILLS (chills) and NAUSEA (nausea). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, SENSATION OF FOREIGN BODY (felt like something foreign put in my body), FEELING ABNORMAL (hard to describe, felt like a steroid shot), INFLUENZA LIKE ILLNESS (severe flu like symptoms), HYPERHIDROSIS (sweats), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.  The patient took Ibuprofen which didn't help.
After the first vaccine on 2/6/2021,  I did not have any reaction except a sore arm until 2/10/2021 when developed a bad headache causing me to leave work.  When I awoke on 2/11/21 I felt worse as the day went on until I had complete flu like symptoms.  On Friday, 2/12, I went to my primary care doctor and they did a COVID-19 test which was negative.  Hence, I just waited for the reaction to go away,  I was not better and able to resume normal activity until 2/15/21.  I did decide to get the second shot as I was not entirely sure it was a result of the vaccine. On 2/27/2021, I received the second vaccination.  Again, the immediate side effect was only a sore arm. On the following Monday (3/1/2021) see cont.I began to have what I thought was muscle aches and pains around the mid section on my body but they were manageable.  On Tuesday and Wednesday (3/3/2021) the pain and area of the pain spread and intensified.  I was unable to sleep or find a comfortable position and was losing strength and knew I needed medical attention as I was afraid it was a heart issue.  My husband took me to the ER (3/4/2021).  The ER doctor ran a CT scan with contrast and the result was a blood clot in my right lung and pneumonia in my left lung along with pleurisy. I was then admitted to Clinic on 3/4/2021.  I remained in the hospital until 3/7/2021.  There I was treated with IV antibiotics, warfarin, Lovenox (80mg), and pain medication for the pleurisy. I was also on a full time heart monitor and my heart was checked several times. Since returning home, I finished a dose of two antibiotics and am using an inhaler to help with breathing.  I have also just finished a long dose of steriods.  My INR is still not regulated to the therapeutic level.  Prior to this reaction, I was in the therapeutic range and had been checked.  As of 4/3/2021 I am at 1.8 not in the 2-3 range and have increased my dose from before the reaction at 7.5 mg to 9.0 mg daily.
After dose two - immediate feeling of fogginess then twelve hours later severe chills and headaches  Muscle and joint aches along with headache lasting 48 hours